Potential role of hybrid positron emission tomography in pre-operative assessment of primary salivary gland carcinomas
The added value of hybrid positron emission tomography is increasingly recognised in head and neck cancer. However, its potential role in salivary gland carcinomas has been scarcely investigated. A consecutive cohort of 45 salivary gland carcinoma patients who underwent pre-therapeutic hybrid positr...
Saved in:
Published in | Journal of laryngology and otology Vol. 137; no. 5; pp. 551 - 555 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Cambridge, UK
Cambridge University Press
01.05.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The added value of hybrid positron emission tomography is increasingly recognised in head and neck cancer. However, its potential role in salivary gland carcinomas has been scarcely investigated.
A consecutive cohort of 45 salivary gland carcinoma patients who underwent pre-therapeutic hybrid positron emission tomography and surgical resection was reviewed. This study investigated whether maximum standardised uptake value correlated with tumour phenotype.
Tumours of high-grade disease on histology (salivary duct carcinoma, carcinoma ex pleomorphic adenoma) had higher maximum standardised uptake value (Kruskal-Wallis test,
= 0.011) than low-grade tumours (adenoid cystic carcinoma and acinic cell carcinoma). Patients with pathologically confirmed node-positive disease had significantly higher maximum standardised uptake value of the primary tumour than patients with pathologically confirmed node-negative disease (Kruskal-Wallis test,
= 0.012).
Maximum standardised uptake value of the primary tumour may guide clinical decision-making in patients with salivary gland carcinomas, as a high maximum standardised uptake value is associated with high-grade tumour histology and the presence of lymph node metastases. Clinicians may consider more aggressive surgery for these patients. |
---|---|
AbstractList | Abstract
Objective
The added value of hybrid positron emission tomography is increasingly recognised in head and neck cancer. However, its potential role in salivary gland carcinomas has been scarcely investigated.
Methods
A consecutive cohort of 45 salivary gland carcinoma patients who underwent pre-therapeutic hybrid positron emission tomography and surgical resection was reviewed. This study investigated whether maximum standardised uptake value correlated with tumour phenotype.
Results
Tumours of high-grade disease on histology (salivary duct carcinoma, carcinoma ex pleomorphic adenoma) had higher maximum standardised uptake value (Kruskal–Wallis test,
p
= 0.011) than low-grade tumours (adenoid cystic carcinoma and acinic cell carcinoma). Patients with pathologically confirmed node-positive disease had significantly higher maximum standardised uptake value of the primary tumour than patients with pathologically confirmed node-negative disease (Kruskal–Wallis test,
p
= 0.012).
Conclusion
Maximum standardised uptake value of the primary tumour may guide clinical decision-making in patients with salivary gland carcinomas, as a high maximum standardised uptake value is associated with high-grade tumour histology and the presence of lymph node metastases. Clinicians may consider more aggressive surgery for these patients. ObjectiveThe added value of hybrid positron emission tomography is increasingly recognised in head and neck cancer. However, its potential role in salivary gland carcinomas has been scarcely investigated.MethodsA consecutive cohort of 45 salivary gland carcinoma patients who underwent pre-therapeutic hybrid positron emission tomography and surgical resection was reviewed. This study investigated whether maximum standardised uptake value correlated with tumour phenotype.ResultsTumours of high-grade disease on histology (salivary duct carcinoma, carcinoma ex pleomorphic adenoma) had higher maximum standardised uptake value (Kruskal–Wallis test, p = 0.011) than low-grade tumours (adenoid cystic carcinoma and acinic cell carcinoma). Patients with pathologically confirmed node-positive disease had significantly higher maximum standardised uptake value of the primary tumour than patients with pathologically confirmed node-negative disease (Kruskal–Wallis test, p = 0.012).ConclusionMaximum standardised uptake value of the primary tumour may guide clinical decision-making in patients with salivary gland carcinomas, as a high maximum standardised uptake value is associated with high-grade tumour histology and the presence of lymph node metastases. Clinicians may consider more aggressive surgery for these patients. The added value of hybrid positron emission tomography is increasingly recognised in head and neck cancer. However, its potential role in salivary gland carcinomas has been scarcely investigated. A consecutive cohort of 45 salivary gland carcinoma patients who underwent pre-therapeutic hybrid positron emission tomography and surgical resection was reviewed. This study investigated whether maximum standardised uptake value correlated with tumour phenotype. Tumours of high-grade disease on histology (salivary duct carcinoma, carcinoma ex pleomorphic adenoma) had higher maximum standardised uptake value (Kruskal-Wallis test, = 0.011) than low-grade tumours (adenoid cystic carcinoma and acinic cell carcinoma). Patients with pathologically confirmed node-positive disease had significantly higher maximum standardised uptake value of the primary tumour than patients with pathologically confirmed node-negative disease (Kruskal-Wallis test, = 0.012). Maximum standardised uptake value of the primary tumour may guide clinical decision-making in patients with salivary gland carcinomas, as a high maximum standardised uptake value is associated with high-grade tumour histology and the presence of lymph node metastases. Clinicians may consider more aggressive surgery for these patients. |
Author | Rupp, N J Hüllner, M W Freiberger, S N Morand, G B Broglie, M A Karimian, S |
Author_xml | – sequence: 1 givenname: S surname: Karimian fullname: Karimian, S organization: 1Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Zurich, Zurich, Switzerland – sequence: 2 givenname: M W surname: Hüllner fullname: Hüllner, M W organization: 2Faculty of Medicine, University of Zurich, Zurich, Switzerland – sequence: 3 givenname: N J surname: Rupp fullname: Rupp, N J organization: 2Faculty of Medicine, University of Zurich, Zurich, Switzerland – sequence: 4 givenname: S N surname: Freiberger fullname: Freiberger, S N organization: 2Faculty of Medicine, University of Zurich, Zurich, Switzerland – sequence: 5 givenname: M A surname: Broglie fullname: Broglie, M A organization: 1Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Zurich, Zurich, Switzerland – sequence: 6 givenname: G B orcidid: 0000-0002-6150-6772 surname: Morand fullname: Morand, G B email: gregoire.morand@mail.mcgill.ca organization: 1Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Zurich, Zurich, Switzerland |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35729688$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kEtLxDAUhYOMOA_9AW4k4LqaV5tkKYMvGFBQ1yVN05kMbVKTzsD8e1um6kJc3Qvn3O9wzxxMnHcGgEuMbjDC_PYNIUIITjEhCGHG0xMww5yJJGUZmoDZICeDPgXzGLeoN3FEzsCUppzITIgZ2L_6zrjOqhoGXxvoK7g5FMGWsPXRdsE7aBobo-2Xzjd-HVS7OUDrYBtM4lsTVGf3BqoYTYxNjxoQbbCNCgcYVW33w7KulSuhVkFb5xsVz8FppepoLsa5AB8P9-_Lp2T18vi8vFslmgraJYRlTGecoSIzuOAlThEyWpcZpQwpJiXVWnAuhMQ8pUbhVKKK4YJmmBVYF3QBro_cNvjPnYldvvW74PrInAhEBJGSyN6Fjy4dfIzBVPn4QI5RPjSd_2m6v7kaybuiMeXPxXe1vYGOUNUMha7Nb_b_2C9eFIrx |
CitedBy_id | crossref_primary_10_1002_cncr_34932 crossref_primary_10_1038_s41598_024_60200_9 |
Cites_doi | 10.1016/j.neo.2021.03.008 10.1097/00003072-200503000-00005 10.1038/s41598-020-73914-3 10.1148/radiol.14140090 10.1148/radiology.192.1.8208973 10.1245/s10434-012-2716-5 10.1148/radiol.2382041977 10.3389/fonc.2020.01670 10.1038/s41598-018-30111-7 |
ContentType | Journal Article |
Copyright | Copyright © The Author(s), 2022. Published by Cambridge University Press on behalf of J.L.O. (1984) LIMITED Copyright © The Author(s), 2022. Published by Cambridge University Press on behalf of J.L.O. (1984) LIMITED. This work is licensed under the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: Copyright © The Author(s), 2022. Published by Cambridge University Press on behalf of J.L.O. (1984) LIMITED – notice: Copyright © The Author(s), 2022. Published by Cambridge University Press on behalf of J.L.O. (1984) LIMITED. This work is licensed under the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | IKXGN CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7RV 7TK 7X7 7XB 88E 88I 8AF 8AO 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. KB0 M0S M1P M2P NAPCQ PQEST PQQKQ PQUKI PRINS Q9U S0X |
DOI | 10.1017/S0022215122001475 |
DatabaseName | Cambridge University Press Wholly Gold Open Access Journals Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) ProQuest Nursing & Allied Health Database Neurosciences Abstracts ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Science Database (Alumni Edition) STEM Database ProQuest Pharma Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials AUTh Library subscriptions: ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Science Database (ProQuest) Nursing & Allied Health Premium ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic SIRS Editorial |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef ProQuest Central Student ProQuest Central Essentials SIRS Editorial ProQuest Health & Medical Complete (Alumni) ProQuest AP Science ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Pharma Collection ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Medical Library (Alumni) ProQuest Science Journals (Alumni Edition) ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) Neurosciences Abstracts ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest Central (Alumni) |
DatabaseTitleList | CrossRef ProQuest Central Student MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: IKXGN name: Cambridge University Press Wholly Gold Open Access Journals url: http://journals.cambridge.org/action/login sourceTypes: Publisher – sequence: 4 dbid: BENPR name: AUTh Library subscriptions: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1748-5460 |
EndPage | 555 |
ExternalDocumentID | 10_1017_S0022215122001475 35729688 |
Genre | Journal Article |
GroupedDBID | --- -1D -1F -2P -2V -E. -~6 -~N .55 .FH .GJ 09C 09E 0E1 0R~ 123 1CY 29K 3O- 3V. 4.4 53G 5RE 5VS 74X 74Y 7RV 7X7 7~V 88E 88I 8AF 8AO 8FI 8FJ 8R4 8R5 9M5 AAAZR AABES AABWE AACJH AAEED AAGFV AAKTX AAMNQ AAQQT AARAB AASVR AAUIS AAUKB AAWTL ABBXD ABBZL ABITZ ABJNI ABKKG ABLJU ABMYL ABQTM ABROB ABUWG ABVFV ABWCF ABXAU ABZCX ABZUI ACBMC ACCHT ACETC ACGFO ACGFS ACGOD ACIMK ACMRT ACPRK ACQFJ ACREK ACUIJ ACUYZ ACWGA ACYZP ACZBM ACZUX ADAZD ADBBV ADDNB ADFEC ADGEJ ADKIL ADOCW ADOVH ADOVT ADVJH AEBAK AEBPU AEHGV AEMTW AENCP AENEX AENGE AEYHU AEYYC AFFNX AFFUJ AFKQG AFKRA AFKSM AFLOS AFLVW AFUTZ AGABE AGJUD AGLWM AGOOT AHLTW AHMBA AHQXX AHRGI AI. AIGNW AIHIV AIOIP AISIE AJ7 AJCYY AJPFC AJQAS AKZCZ ALMA_UNASSIGNED_HOLDINGS ALVPG ANPSP AQJOH AQVPL ARABE ARZZG ATUCA AUXHV AYIQA AZGZS AZQEC BBLKV BCGOX BENPR BESQT BGHMG BJBOZ BKEYQ BLZWO BMAJL BPHCQ BQFHP BRIRG BVXVI C0O CAG CBIIA CCPQU CCQAD CCUQV CDIZJ CFAFE CFBFF CGQII CHEAL CJCSC COF CS3 D-I DC4 DOHLZ DU5 DWQXO EBS EGQIC EJD EX3 F5P FYUFA GNUQQ HCIFZ HG- HMCUK HST HZ~ I.6 I.7 I.9 IH6 IKXGN IOEEP IOO IS6 I~P J36 J38 J3A J5H JHPGK JQKCU JVRFK KAFGG KC5 KCGVB KFECR L7B L98 LHUNA LSO LW7 M-V M1P M2P M2Q M7~ M8. NAPCQ NIKVX NMFBF NZEOI O9- OHT P2P PCD PQQKQ PROAC PSQYO Q2X RCA ROL RR0 RWL RXW S0X S6- S6U SAAAG SY4 T9M TAE TWZ UKHRP UT1 UU6 VH1 WFFJZ WH7 WOW WQ3 WXU WXY WYP X7M Z0Y ZDLDU ZGI ZJOSE ZMEZD ZXP ZYDXJ ~V1 ABVZP ALIPV CGR CTKSN CUY CVF ECM EIF NPM AAYXX CITATION 7TK 7XB 8FK K9. PQEST PQUKI PRINS Q9U |
ID | FETCH-LOGICAL-c383t-2464c6740b6e1b7d1500eccd63340a4993cc8778891753ea1590f41b3614b1cb3 |
IEDL.DBID | 7X7 |
ISSN | 0022-2151 |
IngestDate | Thu Oct 10 20:02:50 EDT 2024 Thu Sep 26 18:32:42 EDT 2024 Wed Oct 16 00:39:48 EDT 2024 Wed Mar 13 05:53:55 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | Radiopharmaceuticals Fluorodeoxyglucose F18 Salivary Gland Neoplasms |
Language | English |
License | http://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c383t-2464c6740b6e1b7d1500eccd63340a4993cc8778891753ea1590f41b3614b1cb3 |
ORCID | 0000-0002-6150-6772 |
OpenAccessLink | https://www.cambridge.org/core/product/identifier/S0022215122001475/type/journal_article |
PMID | 35729688 |
PQID | 2802829929 |
PQPubID | 41857 |
PageCount | 5 |
ParticipantIDs | proquest_journals_2802829929 crossref_primary_10_1017_S0022215122001475 pubmed_primary_35729688 cambridge_journals_10_1017_S0022215122001475 |
PublicationCentury | 2000 |
PublicationDate | 2023-05-01 |
PublicationDateYYYYMMDD | 2023-05-01 |
PublicationDate_xml | – month: 05 year: 2023 text: 2023-05-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Cambridge, UK |
PublicationPlace_xml | – name: Cambridge, UK – name: England – name: Devon |
PublicationTitle | Journal of laryngology and otology |
PublicationTitleAlternate | J. Laryngol. Otol |
PublicationYear | 2023 |
Publisher | Cambridge University Press |
Publisher_xml | – name: Cambridge University Press |
References | 2005; 30 2018; 8 2021; 23 2020; 10 1994; 192 2014; 273 2006; 238 2013; 20 von Schulthess (S0022215122001475_ref1) 2006; 238 Uchida (S0022215122001475_ref5) 2005; 30 Kim (S0022215122001475_ref10) 2013; 20 Morand (S0022215122001475_ref4) 2018; 8 Stadler (S0022215122001475_ref2) 2020; 10 Keyes (S0022215122001475_ref6) 1994; 192 Huellner (S0022215122001475_ref9) 2014; 273 Morand (S0022215122001475_ref3) 2020; 10 El-Naggar (S0022215122001475_ref7) 2017 Freiberger (S0022215122001475_ref8) 2021; 23 |
References_xml | – volume: 238 start-page: 405 year: 2006 article-title: Integrated PET/CT: current applications and future directions publication-title: Radiology – volume: 10 start-page: 16689 year: 2020 article-title: Predictive value of SUVmax changes between two sequential post-therapeutic FDG-PET in head and neck squamous cell carcinomas publication-title: Sci Rep – volume: 192 start-page: 99 year: 1994 end-page: 102 article-title: Salivary gland tumors: pretherapy evaluation with PET publication-title: Radiology – volume: 20 start-page: 899 year: 2013 end-page: 905 article-title: Utility of 18F-FDG PET/CT for detecting neck metastasis in patients with salivary gland carcinomas: preoperative planning for necessity and extent of neck dissection publication-title: Ann Surg Oncol – volume: 273 start-page: 859 year: 2014 article-title: Whole-body nonenhanced PET/MR versus PET/CT in the staging and restaging of cancers: preliminary observations publication-title: Radiology – volume: 8 start-page: 11817 year: 2018 article-title: Maximum standardized uptake value (SUVmax) of primary tumor predicts occult neck metastasis in oral cancer publication-title: Sci Rep – volume: 10 start-page: 1670 year: 2020 article-title: Histometabolic tumor imaging of hypoxia in oral cancer: clinicopathological correlation for prediction of an aggressive phenotype publication-title: Front Oncol – volume: 30 start-page: 170 year: 2005 article-title: Diagnostic value of FDG PET and salivary gland scintigraphy for parotid tumors publication-title: Clin Nucl Med – volume: 23 start-page: 473 year: 2021 article-title: SalvGlandDx – a comprehensive salivary gland neoplasm specific next generation sequencing panel to facilitate diagnosis and identify therapeutic targets publication-title: Neoplasia – volume: 23 start-page: 473 year: 2021 ident: S0022215122001475_ref8 article-title: SalvGlandDx – a comprehensive salivary gland neoplasm specific next generation sequencing panel to facilitate diagnosis and identify therapeutic targets publication-title: Neoplasia doi: 10.1016/j.neo.2021.03.008 contributor: fullname: Freiberger – volume: 30 start-page: 170 year: 2005 ident: S0022215122001475_ref5 article-title: Diagnostic value of FDG PET and salivary gland scintigraphy for parotid tumors publication-title: Clin Nucl Med doi: 10.1097/00003072-200503000-00005 contributor: fullname: Uchida – volume: 10 start-page: 16689 year: 2020 ident: S0022215122001475_ref2 article-title: Predictive value of SUVmax changes between two sequential post-therapeutic FDG-PET in head and neck squamous cell carcinomas publication-title: Sci Rep doi: 10.1038/s41598-020-73914-3 contributor: fullname: Stadler – volume: 273 start-page: 859 year: 2014 ident: S0022215122001475_ref9 article-title: Whole-body nonenhanced PET/MR versus PET/CT in the staging and restaging of cancers: preliminary observations publication-title: Radiology doi: 10.1148/radiol.14140090 contributor: fullname: Huellner – volume: 192 start-page: 99 year: 1994 ident: S0022215122001475_ref6 article-title: Salivary gland tumors: pretherapy evaluation with PET publication-title: Radiology doi: 10.1148/radiology.192.1.8208973 contributor: fullname: Keyes – volume: 20 start-page: 899 year: 2013 ident: S0022215122001475_ref10 article-title: Utility of 18F-FDG PET/CT for detecting neck metastasis in patients with salivary gland carcinomas: preoperative planning for necessity and extent of neck dissection publication-title: Ann Surg Oncol doi: 10.1245/s10434-012-2716-5 contributor: fullname: Kim – volume-title: WHO Classification of Head and Neck Tumours year: 2017 ident: S0022215122001475_ref7 contributor: fullname: El-Naggar – volume: 238 start-page: 405 year: 2006 ident: S0022215122001475_ref1 article-title: Integrated PET/CT: current applications and future directions publication-title: Radiology doi: 10.1148/radiol.2382041977 contributor: fullname: von Schulthess – volume: 10 start-page: 1670 year: 2020 ident: S0022215122001475_ref3 article-title: Histometabolic tumor imaging of hypoxia in oral cancer: clinicopathological correlation for prediction of an aggressive phenotype publication-title: Front Oncol doi: 10.3389/fonc.2020.01670 contributor: fullname: Morand – volume: 8 start-page: 11817 year: 2018 ident: S0022215122001475_ref4 article-title: Maximum standardized uptake value (SUVmax) of primary tumor predicts occult neck metastasis in oral cancer publication-title: Sci Rep doi: 10.1038/s41598-018-30111-7 contributor: fullname: Morand |
SSID | ssj0001702 |
Score | 2.3970995 |
Snippet | The added value of hybrid positron emission tomography is increasingly recognised in head and neck cancer. However, its potential role in salivary gland... Abstract Objective The added value of hybrid positron emission tomography is increasingly recognised in head and neck cancer. However, its potential role in... ObjectiveThe added value of hybrid positron emission tomography is increasingly recognised in head and neck cancer. However, its potential role in salivary... |
SourceID | proquest crossref pubmed cambridge |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 551 |
SubjectTerms | Adenoid Adenoma Adenoma, Pleomorphic - diagnostic imaging Adenoma, Pleomorphic - surgery Carcinoma Carcinoma, Adenoid Cystic - pathology Decision making Exocrine glands Fluorodeoxyglucose F18 Head & neck cancer Histology Humans Lymph nodes Magnetic resonance imaging Main Article Metabolism Metastases Metastasis Oral cancer Otolaryngology Patients Phenotypes Positron emission tomography Positron-Emission Tomography - methods Salivary gland Salivary Gland Neoplasms - diagnostic imaging Salivary Gland Neoplasms - pathology Salivary Gland Neoplasms - surgery Salivary Glands - pathology Statistical analysis Tomography Tumors Variables |
SummonAdditionalLinks | – databaseName: Cambridge University Press Wholly Gold Open Access Journals dbid: IKXGN link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LS8QwEB7WXRAv4tvVVXLwJJZtm7RpjyK-2cWDwt5Kk6bowXbZrYL_3pk2W18oeOshTJNM6XyT-fINwFHuq1hkuXRkELuO0Kl24iyNnYDTNc1Yub6iy8mjcXj1IG4mwaQDk8VdGKJVthoHdSW_7o82beRPh09Zw6ExM7rji7GNAhbRgoQMhnRoObQuSOzGL0HP55izd6F3fTu5HLd_aU-6rZI4WVlUPGs56W-WP-sufI1fv4DSOjhdrMGqRZXstJnNOnRMsQHLI1s334TXu7KiJeEYohOyMmePb_QmVpO2ZmXBqO8bnZyxqny2MtbsqWDEEimnptEHZ2mr40kmpo1SBZunVE_Ch7ofCNPUnqgg3tEWPFyc359dObbjgqMxU60cX4RCh1K4KjSekhmiRRd9nIWcCzfF5IhrHUnMmmMS-DQpYiE3F57iGOSVpxXfhm5RFmYXWKA9jeAsQ0yFAVCaiOeGx4HJ_dhkvlR9OGn3NLFOmycN50wmP1zQh-PFtid2dX8NHiwc82Haj-qqMcLBPuw0zmot8QBzjDCK9v43qX1Yoe7zDf9xAN1q9mIOEKNU6tB-bu_1sN_d priority: 102 providerName: Cambridge University Press |
Title | Potential role of hybrid positron emission tomography in pre-operative assessment of primary salivary gland carcinomas |
URI | https://www.cambridge.org/core/product/identifier/S0022215122001475/type/journal_article https://www.ncbi.nlm.nih.gov/pubmed/35729688 https://www.proquest.com/docview/2802829929 |
Volume | 137 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3PS8MwFA66gXgRfzudIwdPYrBt0qY5icp0KhtDHPQ2mjRFD7Zzq4L_vXlt2iHiTu0hTWlemve9vC_fQ-gs9aRgScoJ94VDmIoVEUksiE_hmKaQjifhcPJwFAwm7DHyI7vhtrC0ynpNLBfqJFewR37phWXSz3jzq9kHgapRkF21JTTWUdv1nAAoXTxqAi6QhmnUwsG11VnNUjIaIh1wd0AqYkAzXGor_PZR_wDP0gHdbaMtixzxdWXqHbSms120MbS58T30Nc4LoP6YNkAZxHmKX7_hTbgkZs3zDENtN9gdw0X-bqWq8VuGgQmSz3SlAY7jRqsTuphVahR4EUPOyNyUNT-wghJEGXCL9tHkrv9yOyC2qgJRJhotiMcCpgLOHBloV_LEIELH2DEJKGVObAIgqlTITWQsQMRTxwbvOClzJTWOXLpK0gPUyvJMHyHsK1cZAJYY3GScHNchTTUVvk49oROPyw66aMZ0av-NxbTilfHpHxN00Hk97FP7dasad2vDLLteTpIOOqyM1fREfRNHBGF4vPrBE7QJFeUrTmMXtYr5pz41uKOQvXJy9VD7pj8aP5vrw1N0P_oBh0jViQ |
link.rule.ids | 315,783,787,12068,21400,23330,27936,27937,31731,33756,43322,43817,56132,74073,74630 |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV09T8MwED1BkYAF8U359MCEsEhiJ04mhBBVgbZiaKVuUew4goGktAGJf48vcVMhRLcMjqP4bN-d7_k9gMvMkxFPM0GFHzmUq0TRKE0i6jO8phlJx5N4Obk_CLoj_jT2x_bAbWZhlfM9sdqo00LhGfmNF1ZFP-PNbycfFFWjsLpqJTRWYQ15uFDBQIybhAupYRq2cHRt86pmRRmNmQ66OwQVcYQZLrgVfvuofwLPygF1tmHLRo7krjb1DqzofBfW-7Y2vgdfL0WJ0B_TBiGDpMjI6zd-iVTArGmRE9R2w9MxUhbvlqqavOUEkSDFRNcc4CRpuDqxi0nNRkFmCdaMzEOl-UEUShDliC3ah1HnYXjfpVZVgSqTjZbU4wFXgeCODLQrRWoiQsfYMQ0Y405iEiCmVChMZhwhiadOTLzjZNyVzDhy6SrJDqCVF7k-AuIrV5kALDVxk3FyQocs0yzydeZFOvWEbMN1M6axXRuzuMaVifiPCdpwNR_22P7dssanc8Msul5MkjYc1sZqemK-ySOCMDxe_uIFbHSH_V7cexw8n8AmqsvX-MZTaJXTT31mYpBSnlcT7QdBC9Uy |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1NT4NAEN1oTRovxm-rVffgybgpsMDCyRi1qR9terBJb4RdluhBqC2a-O-dgYXGGHvjsCxhZ9h5w7x9Q8hF6sjQTVLBhBdazFWxYmESh8zjeEwzlJYj8XDycOQPJu7j1Jsa_tPC0CrrPbHcqJNc4T_ynhOURT-I5r3U0CLGd_3r2QfDDlJYaTXtNNbJhoAsBX1eTJvkC2ViGuVwDHN1hbOUj8asB0MfEoxcpBwudRZ-x6t_QGgZjPrbZMugSHpTmX2HrOlsl7SHpk6-R77GeYE0IBiD9EGap_T1G59ES5LWPM8o9nnDP2W0yN-NbDV9yyiyQvKZrvTAadzoduIUs0qZgi5irB_BRdn_gypsR5Qhz2ifTPr3L7cDZjosMAWZacEc13eVD8slfW1LkQA6tMCmic-5a8WQDHGlAgFZcoiCnjoG7GOlri05BHVpK8kPSCvLM31EqKdsBWAsAQwFAU_ogKeah55OnVAnjpAdctWsaWS-k0VUccxE9McEHXJZL3tk3m7V4G5tmOXUS4fpkMPKWM1M3IOcwg-C49U3npM2-Fj0_DB6OiGb2Gi-ojp2SauYf-pTgCOFPCv97Adrfdlq |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Potential+role+of+hybrid+positron+emission+tomography+in+pre-operative+assessment+of+primary+salivary+gland+carcinomas&rft.jtitle=Journal+of+laryngology+and+otology&rft.au=Karimian%2C+S&rft.au=H%C3%BCllner%2C+M+W&rft.au=Rupp%2C+N+J&rft.au=Freiberger%2C+S+N&rft.date=2023-05-01&rft.issn=0022-2151&rft.eissn=1748-5460&rft.volume=137&rft.issue=5&rft.spage=551&rft.epage=555&rft_id=info:doi/10.1017%2FS0022215122001475&rft.externalDBID=n%2Fa&rft.externalDocID=10_1017_S0022215122001475 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-2151&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-2151&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-2151&client=summon |